24 Jul 17

Baxter launches NUMETA emulsion for infusion in Europe Baxter International Inc. announced today the European start of NUMETA . NUMETA was launched at the 22nd Annual European Culture of Pediatric and Neonatal Intensive Treatment Medical and Nursing Annual Congress in Hanover, Germany, as the 1st and only triple-chamber program with formulations specifically made to meet the selection of intravenous dietary requirements of neonatal and pediatric sufferers medicament . This premix therapy addresses a significant unmet medical have to support neonatal and pediatric sufferers’ changing daily nutritional requirements with ready-to-use IV nourishment. Many preterm infants depend on IV nutrition, also called parenteral diet , at birth to meet up all or component of their daily dietary requirements.

article

It obviously demonstrates their desire to increase the ongoing collaboration beyond the prevailing contract to provide 20 million dosages of IMVAMUNE and we anticipate exploring this exciting chance. .. Bavarian Nordic starts negotiations with U.S. To secure a agreement to build up a freeze-dried edition of smallpox vaccine Bavarian Nordic A/S declared today that the united states authorities have initiated negotiations for a fresh contract to build up a freeze-dried version of the IMVAMUNE smallpox vaccine. This potential fresh project could have no impact on the ongoing RFP-3 BARDA agreement for the procurement of 20 million dosages of IMVAMUNE and the licensure of the existing liquid-frozen formulation, but represents yet another business opportunity.